← Insider buys
CHRS

Coherus Oncology, Inc. · Healthcare

Director Mats Wahlstrom sold $3.4M of Coherus Oncology, Inc.

Sold$3,430,020
$17.15Price
200,000Shares
−100%Stake

What CHRS did after the filing

Prices for CHRS after this filing aren't in yet.

Traded Wed, Jun 17. Filed Fri, Jun 19, 12:33 PM ET, during the session. Not investment advice.